[1]
J. Miranda Poma, L. Ostios Garcia, J. Villamayor Sanchez, and G. D’errico, “What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events”, Allergol Immunopathol, vol. 47, no. 3, pp. 303–308, Jun. 2019, Accessed: Apr. 24, 2026. [Online]. Available: https://www.all-imm.com/index.php/aei/article/view/309